Login Register
icon_bulk_orderBulk order Acrobiosystems for ChineseChinese
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
SARS-CoV-2 | CD24 | CD73 | Trimer | CD19 | PD-1
0
There is no goods in the shopping cart !
My Cart
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > IL-15 R alpha

IL-15 R alpha

IL-15 R alpha Molecule Information

Name:Interleukin-15 receptor subunit alpha
Target Synonym:Interleukin 15 Receptor, Alpha,Interleukin 15 Receptor Alpha Isoform IC3,sIL-15 receptor subunit alpha,IL-15R-Alpha,Interleukin-15 Receptor alpha Subunit,sIL-15RA,sIL-15R-alpha,Interleukin 15 Receptor Alpha Isoform IC2,Interleukin 15 Receptor Alpha Isofor
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:8
Lastest Research Phase:Phase 3 Clinical

IL-15 R alpha Protein Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
ILA-H82F4 Human Biotinylated Human IL-15 R alpha / CD215 Protein, Fc,Avitag™
ILA-H82F4-structure
ILA-H82F4-sds
ILA-H82F4-elisa_1
ILA-H5253 Human Human IL-15 R alpha / CD215 Protein, Fc Tag
ILA-H5253-structure
ILA-H5253-sds
ILA-H5253-elisa_1

IL-15 R alpha Part of Bioactivity data

ILA-H5253-Cell-based assay
Human FcRn Heterodimer Protein Cell_Base

Human IL-15 R alpha, Fc Tag (Cat. No. ILA-H5253) inhibits IL-15-dependent proliferation of CTLL-2 cells. The ED50 for this effect is 2.77-4.20 ng/mL (Routinely tested).

Protocol
ILA-H5253-ELISA
Human IL-15 R alpha, Fc TagHuman IL-15 R alpha, Fc Tag (Cat. No. ILA-H5253) ELISA bioactivity

Immobilized Human IL-15 R alpha, Fc Tag (Cat. No. ILA-H5253) at 2 μg/mL (100 μL/well) can bind Biotinylated Human IL-15, Fc,Avitag (Cat. No. IL5-H82F3) with a linear range of 2-78 ng/mL (QC tested).

Protocol
ILA-H82F4-ELISA
Biotinylated Human IL-15 R alpha, Fc,AvitagBiotinylated Human IL-15 R alpha, Fc,Avitag (Cat. No. ILA-H82F4) ELISA bioactivity

Immobilized Human IL-15, Tag Free (Cat. No. IL5-H4117) at 2 μg/mL (100 μL/well) can bind Biotinylated Human IL-15 R alpha, Fc,Avitag (Cat. No. ILA-H82F4) with a linear range of 2-39 ng/mL (QC tested).

Protocol

IL-15 R alpha Molecule Synonym Name

IL-15 R alpha,CD215,IL15RA,IL-15RA,IL-15R-alpha

IL-15 R alpha Molecule Background

IL15R is a heterotrimer of IL15RA, IL2RB and IL2RG. IL-15RA, also known as CD215, IL-15 R alpha, is a widely expressed 60 kDa transmembrane glycoprotein. High-affinity receptor for interleukin-15. Can signal both in cis and trans where IL15R from one subset of cells presents IL15 to neighboring IL2RG-expressing cells. Expression of different isoforms may alter or interfere with signal transduction. An interleukin (IL)-15 superagonist/IL-15 receptor ? fusion complex (IL-15SA/IL-15RA; ALT-803) activates the IL-15 receptor on CD8 T cells and NK cells, and has shown significant anti-tumor. Signal transduction involves SYK. Higher levels of soluble sIL-15RA form in comparison with membrane-bound forms is present in all brain structures.

IL-15 R alpha References

IL-15 R alpha Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
SHR-1501 SHR-1501 Phase 1 Clinical Jiangsu Hengrui Medicine Co Ltd Neoplasms Details
Recombinant interleukin 15 (Beijing Kawin Technology) Phase 1 Clinical Beijing Kawin Technology Share-Holding Co Ltd Details
SO-C101 RLI-15; SO-C101; CYP-0150 Phase 1 Clinical Sotio Microsatellite instability-high cancer; Carcinoma, Hepatocellular; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Thymus Neoplasms; Mesothelioma; Urinary Bladder Neoplasms; Biliary Tract Neoplasms; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Stomach Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Renal Cell; Anus Neoplasms; Squamous Cell Carcinoma of Head and Neck; Ovarian Neoplasms Details
NKTR-255 NKTR-255 Phase 2 Clinical Nektar Therapeutics Squamous Cell Carcinoma of Head and Neck; Multiple Myeloma; Colorectal Neoplasms; Lymphoma, Non-Hodgkin Details
XmAb24306 XmAb-24306; RG-6323; RO-7310729 Phase 1 Clinical Xencor Solid tumours Details
Heterodimeric interleukin 15 NIZ985 Phase 1 Clinical Novartis Pharma Ag Solid tumours; Lymphoma Details
Inbakicept N-803; ALT-803 Phase 3 Clinical Nantkwest, Altor Bioscience Corporation Chordoma; Uterine Cervical Neoplasms; Bacterial Infections; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Fallopian Tube Neoplasms; Lung Neoplasms; Carcinoma, Squamous Cell; Thyroid Neoplasms; Lymphoma, Non-Hodgkin; Peritoneal Neoplasms; Colorectal Neoplasms; Microsatellite Instability; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Breast Neoplasms; Ovarian Neoplasms; Urinary Bladder Neoplasms; Multiple Myeloma; Small Cell Lung Carcinoma; Colonic Neoplasms; Coronavirus Disease 2019 (COVID-19); Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Pancreatic Neoplasms; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Solid tumours; Hematologic Diseases; HIV Infections Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
中文网站|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap